CardioScripts (@CardioScripts) header
CardioScripts (@CardioScripts) profile picture

A Cardiology Pharmacy Podcast reviewing recent cardiology literature with hosts @SchwietTMac & @val_smartan; podcast editing @tweetlessnathan

Joined September 2019
Photo by CardioScripts (@CardioScripts)Photo by CardioScripts (@CardioScripts)Photo by CardioScripts (@CardioScripts)Photo by CardioScripts (@CardioScripts)Photo by CardioScripts (@CardioScripts)Photo by CardioScripts (@CardioScripts)Photo by CardioScripts (@CardioScripts)Photo by CardioScripts (@CardioScripts)Photo by CardioScripts (@CardioScripts)Photo by CardioScripts (@CardioScripts)
CardioScripts retweeted
Thank you @CardioScripts for letting me come back and talk a bit about all things bempedoic acid and #cholesterol management!! Truly a pleasure and honor to be back!
Happy Fall! Fall into a great discussion of the CLEAR Outcomes trial as @JurgaTomek discusses the current landscape of cholesterol management! @accpcardprn apple.co/346sc9q
1
7
1,111
Who else could highlight their favorite trials while also referencing Back to the Future, Sound of Music, and Las Vegas? It was as an absolute blast working with @CardioScripts ... links to both episodes below CS: open.spotify.com/episode/0LH… PTD: open.spotify.com/episode/6ap…
ICYMI: The CardioScripts crew joined @PharmacyToDose podcast creator and host, @TweeetinPete, to discuss his Top 3 Trials in cardiology. Listen to our discussion with Nick on CardioScripts and find the full episode on the Pharmacy to Dose podcast! 💊🫀💉 apple.co/346sc9q
1
4
1,493
CardioScripts retweeted
Favorite landmark trial: VHeFT 1: started the avalanche of GDMT data as the 1st therapy to have proven benefit...only to be outdone shortly thereafter by the ACEI trials.
3
1
3
550
CardioScripts retweeted
The CAST trial! A lesson in the temptation of the inferential leap. “if we stop the arrhythmias-->we'll stop sudden deaths.” A reminder when reacting to surrogates, risk markers etc Plus the investigators' courage to randomize and study an established practice
2
1
3
570
CardioScripts retweeted
UHCOP's @val_smartan talks results of DELIVER trial on diabetes drug dapagliflozin in heart failure patients with cardiology pharmacy specialist @JurgaTomek in fresh @CardioScripts episode
Take a break from debating if it's too early to listen to Christmas music (is it?) and check out the newest CardioScripts episode with @JurgaTomek and his thoughts on the DELIVER trial. It's a pretty sweet episode! @accpcardprn apple.co/346sc9q
1
5
CardioScripts retweeted
Had an absolute blast recording this episode! Thank you @CardioScripts for letting me ramble a bit about heart failure and what not. – at Ann Arbor, MI
Take a break from debating if it's too early to listen to Christmas music (is it?) and check out the newest CardioScripts episode with @JurgaTomek and his thoughts on the DELIVER trial. It's a pretty sweet episode! @accpcardprn apple.co/346sc9q
1
10
🚨It’s finally here! #PARADISEMI 🚨 Post-MI, ACE/ARB should still be standard of care for new systolic dysfunction. And PLEASE start that MRA before discharge in patients meeting EPHESUS criteria. @accpcardprn @CardioScripts
1
10
56
CardioScripts retweeted
Listened to it this morning. Masterclass on evaluating primary literature 🧐
👑 Check out our latest episode with @agoncha259 discussing the EMPEROR-Preserved trial👑 Is the reign of SGLT2 inhibitors here to stay? @accpcardprn apple.co/346sc9q
1
1
In today's Pharmacy Grand Rounds, @MayoClinicHS PGY1 resident Bobby Schroeder makes heart failure do BOOM Sacu/Valsa with a review of this combo therapy. Follow along with live tweets here starting at 11am CST! #TwitteRx @CardioScripts @accpcardprn
1
5
1
15
Review of EMPEROR PRESERVED study
1
1
1
In today's Pharmacy Grand Rounds, @MayoPharmRes PGY1 resident @pharmdiv makes our cardiology hearts go BOOM BOOM with updates in HFpEF treatment. Follow along with live tweets here starting at 11am CST! #TwitteRx @mayoclinicshs @CardioScripts @accpcardprn
1
2
1
21
I had so much fun chatting with @SchwietTMac @CardioScripts about PARADISE-MI. Spoiler alert: our post-ACS paradise includes more MRA use #cardiotwitter #EPHESUS @accpcardprn
Planning your summer vacation? Trouble finding paradise? Look no further as @StephDwyer21 discusses the PARADISE-MI trial. Sure to make you feel like you're in a paradise of your own! @accpcardprn apple.co/346sc9q
2
23
#ACC21 #ACCCVT Pharmacist Poster / Platform Presentations tonight starting at 5 PM CST! We have 200 people registered and LOTS of fabulous research lined up. Last chance to register below. See everyone tonight! @beaverspharmd @olivia_krz @SajniPatel2 okranzacc.wufoo.com/forms/pf…
3
5
2
22
CardioScripts retweeted
So glad you are back. I enjoy listening during my car ride to and from work. Keep up the great work ! @accpcardprn @ACCP @ASHPOfficial
The CardioScripts team is back! Check out our latest trailer and get ready for more literature crusading with great episodes and amazing guests! @accpcardprn apple.co/346sc9q
1
6
This week's ACCP CARDS PRN “Teaching Tuesday” infographic, created by member @saraward_rx, is on the LVAD. Students & residents, what are your experiences in the care of patients with LVADs? Comment below! #cardiotwitter
4
34
6
145
Q: Based on the results of the TRITON-TIMI 38 trial, which two subgroups benefitted from prasugrel over clopidogrel without an increase in bleeding events? #BCCP #BoardPrep
17%STEMI + Female
10%Diabetes + HLD
9%Female + Prior CVA
64%Diabetes + STEMI
263 votes • Final results
2
6
2
14
Just one of the many great takeaways in this podcast: While SGLT2i’s have many benefits in our HF patients, we should first always take into consideration our patient’s specific goals & what their idea of a good QOL is. 👏🏻
New year, new episode, same reigning drug class. Don't miss out as @tedberei discusses the EMPEROR-Reduced trial and SGLT2 inhibitors! @accpcardprn apple.co/346sc9q
1
4
CardioScripts retweeted
Thanks again for having me! – at Wisconsin, USA
New year, new episode, same reigning drug class. Don't miss out as @tedberei discusses the EMPEROR-Reduced trial and SGLT2 inhibitors! @accpcardprn apple.co/346sc9q
1
5
Awesome podcast @tedberei @val_smartan @SchwietTMac, thanks! Question: why do you think that DAPA-HF showed a mortality reduction but not EMPEROR-reduced? Does that impact your decision on which drug to choose in HFrEF? What if they have ASCVD + HFrEF? #cardiotwitter @twitteRx
New year, new episode, same reigning drug class. Don't miss out as @tedberei discusses the EMPEROR-Reduced trial and SGLT2 inhibitors! @accpcardprn apple.co/346sc9q
1
1
5
CardioScripts retweeted
Give this one a listen #cardiotwitter friends. And kudos on the gif selection @CardioScripts 👌
New year, new episode, same reigning drug class. Don't miss out as @tedberei discusses the EMPEROR-Reduced trial and SGLT2 inhibitors! @accpcardprn apple.co/346sc9q
1
1
4